Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 5/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.46 |
| ▸ | PLAAT3 | P53816 | 2/20 | 0.45 |
| ▸ | PLAAT5 | Q96KN8 | 2/20 | 0.45 |
| ▸ | PLAAT2 | Q9NWW9 | 2/20 | 0.45 |
| ▸ | PLAAT4 | Q9UL19 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23199613 | 0.91 | CNR1 (0.51) | CNR1ALDH1A1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL31579654 | 0.82 | CNR1 (0.57) | CNR1ALDH1A1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL4525519 | 0.82 | ALDH1A1 (0.72) | CNR1ALDH1A1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL28067780 | 0.81 | CNR1 (0.49) | CNR1ALDH1A1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL16822086 | 0.80 | HCAR2 (0.44) | CNR1ALDH1A1KMT2ASMN1; SMN2MEN1 | |
| SCHEMBL4582082 | 0.80 | TAAR1 (0.65) | CNR1ALDH1A1SMN1; SMN2TAAR1PLAAT3 | |
| SCHEMBL17513300 | 0.79 | MARS1 (0.48) | CNR1ALDH1A1KMT2AMEN1FABP4 | |
| SCHEMBL11121464 | 0.79 | TACR1 (0.56) | CNR1KMT2AMEN1CYP1A2CYP2D6 | |
| SCHEMBL5705198 | 0.79 | GLA (0.57) | CNR1KMT2ASMN1; SMN2TAAR1LMNA | |
| SCHEMBL21332641 | 0.79 | EPHX2 (0.58) | CNR1ALDH1A1SMN1; SMN2TAAR1PLAAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1419538-A | Integrated process for the preparation of aromatic isocyanates and procedures for effecting the relative intermediate phases | ENICHEM SPA (IT) | 2003-05-21 | — | — | CN | claimed |
| US-20040181094-A1 | Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants | REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE | 2004-09-16 | — | — | US | disclosed |
| CN-1419538-A | Integrated process for the preparation of aromatic isocyanates and procedures for effecting the relative intermediate phases | ENICHEM SPA (IT) | 2003-05-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040181094-A1 | Transition metal oxo complexes as catalysts of synthetic processes involving alkyne reactants | POLR1G, PYM1, APEX1 | CNR1 1784/4885ALDH1A1 3099/4885KMT2A 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.